Colorectal cancer
Conditions
Interventions
This study was conducted with two distinct groups of participants:
1. Patients presenting colorectal symptoms (outpatient group)
2. Patients with clinical diagnosis of colorectal malignancies
This
the two groups were enrolled for different purposes. The outpatient group provided samples for prospective analysis of DNA scores in individuals with a range of colorectal conditions. Investigation of
Sponsors
Colonix Medical Ltd (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Two different groups of participants were recruited: 1. Consecutive outpatients presenting colorectal symptoms and selected for diagnostic full colonoscopy 2. Consecutive patients with clinical diagnosis of colorectal malignancies prepared for operations in the Royal Surrey County Hospital (Guildford) Note: In this small pilot study there was no sex and age limitations. All patients were over 35 of age.
Exclusion criteria
Exclusion criteria: Extensive surgical interventions in the colorectal region in the past
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DNA yields from exfoliated materials (DNA scores) are assessed in terms of their predictive value in detecting the presence of serious colorectal conditions (colorectal cancer and inflammatory bowel disease) | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcome measures | — |
Countries
United Kingdom
Outcome results
None listed